Change in Plaque Characteristics With Atorvastatin (EASY-FIT)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Patients with acute coronary syndrome (myocardial infarction or unstable angina) who will undergo PCI and have at least one atherosclerotic lesion of >25% stenosis other than culprit lesions of current ACS are enrolled. Fibrous cap thickness of a target coronary plaque is evaluated by optical coherence tomography.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
20 Years to 75 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patients with acute coronary syndrome (myocardial infarction or unstable angina) who will undergo PCI.
plasma LDL cholesterol levels : >=100mg/dL and ≤160mg/dL
at least one atherosclerotic lesion of >25% stenosis other than culprit lesions of current ACS
Patients who will undergo coronary bypass surgery.
Patients with major complications during treatment of culprit coronary lesions.
Patients with an atherosclerotic lesion with >50% stenosis at a left main trunk.